Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Пастушков Илья Серафимович
Observed names:
I. S. Pastushkov,
I.S. Pastushkov,
Ilya S. Pastushkov
Institution:
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology
Observed institution:
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology
ORCID:
0009-0000-7110-3785
Observed ORCID:
0009-0000-7110-3785
OpenAlex ID:
A5124227462
Experience in applying pharmacoeconomic modeling using a "decision tree" to determine the volume and cost structure of Hodgkin's lymphoma treatment in HIV-positive and HIV-negative patients
2025
·
Natalia V. Kremneva
, Andrei B. Abrosimov
, et al.
·
Acta medica Eurasica
·
2
PDF
Additional economic burden of HIV infection in treating adult patients with Hodgkin lymphoma
2026
·
A. B. Abrosimov
, N. V. Kremneva
, et al.
·
FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology
·
1
PDF
Methodology of a three-level model for the provision of surgical care to children with oncological and oncohematological diseases
2026
·
S. A. Dukoyan
, A. B. Abrosimov
, et al.
·
Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
Improving cost assessment and health economic evaluation of a new medical technology during clinical approbation: the role of a structured costing tool
2026
·
D.V. Lukyantseva
, Yu.A. Falke
, et al.
·
Medical Technologies Assessment and Choice
Clinical validation as a mechanism for transforming the implementation of innovative medical technologies: ten years of experience at the national medical research center (2015–2025).
2026
·
А.B. Abrosimov
, K.V. Breslavskii
, et al.
·
Manager Zdravookhranenia
PDF
Features of Resource Planning in the Treatment of Hodgkin’s Lymphoma: a Comparative Analysis of Cost Structure Depending on the Patient’s Hiv Status
2026
·
N.V. Kremneva
, A.B. Abrosimov
, et al.
·
Bulletin Biomedicine and sociology
Analysis of the impact on the budget of the appointment of cytogenetic studies before choosing first-line therapy for multiple myeloma.
2026
·
FSBEIHE A. I. Yevdokimov MSMSU MOH Russia
, Y. A. Zabolotneva
, et al.
·
Manager Zdravookhranenia
Экономическая эффективность цитогенетических исследований при множественной миеломе: роль в выборе терапии первой линии.
2026
·
Заболотнева Юлия Александровна
, Семелева Елена Владимировна
, et al.
·
Manager Zdravookhranenia
Дополнительное экономическое бремя, создаваемое ВИЧ-инфекцией при лечении лимфомы Ходжкина у взрослых пациентов
2025
·
Абросимов Андрей Борисович
, Кремнева Наталья Валерьевна
, et al.
·
FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology
Show more works
View as search
Works count:
9
Citation count:
3
H-index:
1
I10-index:
Year
Topic
Type